ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
Dow Jones
43.297,03
0,91%
Euro vs US Dollar
1,04012
0,02%
Bitcoin
95.481,21
-3,85%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Athira Pharma Inc (ATHA) Börsenkurse

Athira Pharma Inc

Athira Pharma Inc (ATHA)

Athena Gold Corporation
0,542
0,0289
(5,63%)
Geschlossen 24 Dezember 10:00PM
Verzögert um 15 Minuten
0,542
0,00
( 0,00% )
Vor Marktöffnung: 10:37AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,542
Gebot
0,542
Fragen
0,598
Volumen
257
0,00 Tagesbereich 0,00
0,4115 52-Wochen-Bereich 4,2984
Marktkapitalisierung
20,959M
Handelsende
0,542
Handelsbeginn
-
Letzte Trade
50
@
0.5426
Letzter Handelszeitpunkt
11:07:14
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
5.049.251
Ausgegebene Aktien
38.669.073
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,18
Gewinn pro Aktie (EPS)
-3,04
Erlöse
1,63M
Nettogewinn
-117,67M

Über Athira Pharma Inc

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.athira.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Athira Pharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ATHA. The last closing price for Athira Pharma was US$0,54. Over the last year, Athira Pharma shares have traded in a share price range of US$ 0,4115 to US$ 4,2984.

Athira Pharma currently has 38.669.073 shares in issue. The market capitalisation of Athira Pharma is US$20,96 million. Athira Pharma has a price to earnings ratio (PE ratio) of -0.18.

ATHA Neueste Nachrichten

Weitere Nachrichten

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND

BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...

06 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

07 November 2024
Edgar (US Regulatory)

Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates

BOTHELL, Wash., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...

07 November 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

29 Oktober 2024
Edgar (US Regulatory)

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting

BOTHELL, Wash., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health...

22 Oktober 2024
GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933

21 Oktober 2024
Edgar (US Regulatory)

Form 8-K - Current report

18 Oktober 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 Oktober 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 Oktober 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 Oktober 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0019-0.3493289207570.54390.5760.51252413530.54369423CS
4-0.116-17.62917933130.6580.67890.51253220770.59705435CS
120.104823.97072278130.43720.82640.412150492510.61057745CS
26-1.768-76.53679653682.313.670.411526829130.66733871CS
52-1.658-75.36363636362.24.29840.411515039250.89235158CS
156-12.458-95.83076923081314.220.41157358692.01846161CS
260-19.408-97.283208020119.9534.790.41156744315.1225192CS

ATHA - Frequently Asked Questions (FAQ)

What is the current Athira Pharma share price?
The current share price of Athira Pharma is US$ 0,542
How many Athira Pharma shares are in issue?
Athira Pharma has 38.669.073 shares in issue
What is the market cap of Athira Pharma?
The market capitalisation of Athira Pharma is USD 20,96M
What is the 1 year trading range for Athira Pharma share price?
Athira Pharma has traded in the range of US$ 0,4115 to US$ 4,2984 during the past year
What is the PE ratio of Athira Pharma?
The price to earnings ratio of Athira Pharma is -0,18
What is the cash to sales ratio of Athira Pharma?
The cash to sales ratio of Athira Pharma is 12,83
What is the reporting currency for Athira Pharma?
Athira Pharma reports financial results in USD
What is the latest annual turnover for Athira Pharma?
The latest annual turnover of Athira Pharma is USD 1,63M
What is the latest annual profit for Athira Pharma?
The latest annual profit of Athira Pharma is USD -117,67M
What is the registered address of Athira Pharma?
The registered address for Athira Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Athira Pharma website address?
The website address for Athira Pharma is www.athira.com
Which industry sector does Athira Pharma operate in?
Athira Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MGIHMillennium Group International Holdings Ltd
US$ 4,26
(178,43%)
11,41M
YJYunji Inc
US$ 3,60
(140,00%)
778,05k
ADDColor Star Technology Company Ltd
US$ 4,38
(102,78%)
4,47M
AIREreAlpha Tech Corporation
US$ 1,90
(38,69%)
4,16M
LICNLichen China Limited
US$ 0,2827
(34,55%)
17,79M
NEUPNeuphoria Therapeutics Inc
 3,88
(-41,48%)
49,09k
HOURHour Loop Inc
US$ 2,89
(-34,32%)
245,52k
DRCTDirect Digital Holdings Inc
US$ 2,61
(-29,65%)
220,85k
BAOSBaosheng Media Group Holdings Ltd
US$ 5,29
(-25,49%)
81,84k
SVRESaverOne 2014 Ltd
US$ 1,14
(-24,50%)
49,09k
LICNLichen China Limited
US$ 0,2827
(34,55%)
17,79M
MGIHMillennium Group International Holdings Ltd
US$ 4,26
(178,43%)
11,41M
KWEKWESST Micro Systems Inc
US$ 0,7024
(26,15%)
5,6M
WAFUWah Fu Education Group Ltd
US$ 2,20
(26,44%)
4,67M
ADDColor Star Technology Company Ltd
US$ 4,38
(102,78%)
4,47M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ATHA
Athira Pharma
BIT
P1T8L0
BNP Paribas Issuance
NASDAQ
PHUN
Phunware
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten